SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bosco & Crossy's stock picks,talk area -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (3388)5/24/2003 2:26:44 PM
From: JoeinIowa  Read Replies (1) | Respond to of 37387
 
Crossy,

The last 4 quarters GORX has been able to show good growth over a year ago but the quarterly numbers for the last year do not show quarter to quarter growth.

quicken.com

Their last four quarters have been 3.7, 4.4, 3.3, 3.3 million in sales. How do you think this quarter will look compared to 3.7M from a year ago? If they can grow 20%/quarter and bring the generics to the market they could rise very nicely.

Joe



To: Crossy who wrote (3388)5/28/2003 4:12:15 AM
From: Steve Misic  Read Replies (1) | Respond to of 37387
 
Crossy,

RE:GORX,
You wrote "They already possess FDA certified production facilities (GCMP cert) and recently hired the necessary qualified personnel to file ANDAs with the FDA."

Can you explain what GCMP and ANDA mean?
I checked out the 10-Q and the 10-K, but I could not find any mention of that segment of the business.

Thanks,
Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News